Vitality Watch

Dossier pubmed review 30-sep-2026
Narrative review or expert overview without new data

Renovascular Disease and Its Impact on Endogenous Kidney Repair: Stem/Progenitor Cells.

Key claim: Renovascular disease impairs endogenous kidney repair by exposing endothelial progenitor cells, MSCs, and tubular regenerative pathways to ischemia, hypertension, RAAS activation, and hypoxia that converge on oxidative stress, mitochondrial dysfunction, senescence, ER stress, and apoptosis.

Abstract

BACKGROUND: Renovascular disease (RVD), a progressive condition characterized by narrowing or occlusion of the renal arteries, is an important cause of secondary hypertension and chronic kidney disease (CKD) in older adults, associated with high cardiovascular morbidity and mortality. Recent evidence suggests that RVD compromises renal repair by impairing complementary vascular, stromal, and tubular repair systems, including endothelial progenitor cells (EPCs), mesenchymal stem/stromal cells (MSCs), and tubular regenerative pathways. SUMMARY: RVD exposes these endogenous repair cells to multiple injurious stressors, including renal ischemia, hypertension, mechanical stretch, renin-angiotensin-aldosterone system (RASS) activation, and hypoxia. These upstream stressors trigger convergent cellular mechanisms, including oxidative stress, mitochondrial dysfunction, epigenetic and post-transcriptional (mRNA/miRNA) alterations, endoplasmic reticulum (ER) stress, cellular senescence, and apoptosis, leading to impaired reparative capacity. Cardiovascular comorbidities, including obesity, diabetes, and metabolic syndrome (MetS), further exacerbate these maladaptive responses. Experimental studies suggest that mitoprotective agents, epigenetic and miRNA modulators, ER-stress inhibitors, and extracellular vesicle (EV)-based therapies may preserve or restore stem/progenitor cell function. KEY MESSAGES: This review summarizes the current understanding of the impact of RVD on endogenous renal repair, focusing on the complementary roles of EPCs, MSCs, and tubular regenerative pathways, including resident renal progenitor cells, scattered tubular-like cells (STCs), and injury-induced epithelial plasticity. We discuss how common pathological stressors converge on shared molecular pathways to impair endogenous repair and highlight emerging therapeutic strategies aimed at preserving or restoring the regenerative capacity of these endogenous repair systems.

Why this matters

Renovascular disease impairs endogenous kidney repair by exposing endothelial progenitor cells, MSCs, and tubular regenerative pathways to ischemia, hypertension, RAAS activation, and hypoxia that converge on oxidative stress, mitochondrial dysfunction, senescence, ER stress, and apoptosis.

Source

Link

Briefing card

Renovascular Disease and Its Impact on Endogenous Kidney Repair: Stem/Progenitor Cells.
Stage: review · pubmed · 30-sep-2026

Renovascular disease impairs endogenous kidney repair by exposing endothelial progenitor cells, MSCs, and tubular regenerative pathways to ischemia, hypertension, RAAS activation, and hypoxia that converge on oxidative stress, mitochondrial dysfunction, senescence, ER stress, and apoptosis.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1155/sci/4007512

build build 880 · 2bcef25 · 2026-11-18